Supriya Lifescience gains ANVISA nod for Esketamine Hydrochloride & files patent for… EP News Bureau Dec 10, 2024 Supriya Lifescience has developed a technique for low-cost manufacturing of Atorvastatin
CDSCO anticipates low inventory of cardiac and anti-diabetic medicines, writes to all pharma… Usha Sharma Apr 26, 2020 The letter to all the associations from the CDSCO has also requested to take urgent, necessary action to ensure sufficient…